查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827394

支架市場按產品類型、材料、交付方式、應用和最終用戶分類—2025-2032 年全球預測

Stents Market by Product Type, Material, Mode of Delivery, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年支架市場規模將成長至 253.3 億美元，複合年成長率為 7.73%。

主要市場統計數據
基準年2024年 139.5億美元
預計2025年 150.1億美元
預測年份：2032年 253.3億美元
複合年成長率（%） 7.73%

關於臨床創新、監管要求和醫療保健服務轉變如何重塑支架和介入器材策略的簡明策略概述

支架在介入醫學、器材工程和衛生系統經濟學的交叉領域中發揮著至關重要的作用。材料科學、手術技術和影像技術的進步，已將支架的治療用途從冠狀動脈介入擴展到神經血管、周邊血管、胃腸道和泌尿器官系統。臨床醫師越來越青睞微創治療，因為這些治療方案恢復時間較短、併發症發生率更低，且可在門診就診，導致採購優先順序和醫療服務模式重塑。

市場參與企業在複雜的監管和報銷環境中營運，需要嚴格的臨床證據和上市後監管。監管機構目前優先考慮長期安全性和實際應用效果，迫使製造商將資料生成功能整合到其產品策略中。同時，醫療保健服務體係正在探索基於價值的合約和與結果掛鉤的採購模式，從而提高了比較臨床效益和成本效益的標準。

本報告整合了技術、臨床和商業性訊號，概述了創新在哪些領域創造差異化價值，以及營運壓力如何推動策略調整。報告旨在為領導者提供清晰的現代動態基準，以便確定投資優先順序、最佳化供應鏈並完善市場策略，從而滿足不斷變化的相關人員期望。

材料突破、設計演變和商業平台策略如何推動支架開發和臨床應用的模式轉移

在技​​術、法規和醫療保健服務整合的推動下，支架領域正在經歷一場變革性的轉變。隨著我們從傳統的不銹鋼材料轉向先進的合金和聚合物技術，支架的性能正在被材料創新所重新定義，這些技術能夠提供更高的柔韌性、滲透性和生物相容性。這些材料的進步使得輸送系統更薄、部署更精確，從而支持其擴展到具有挑戰性的解剖適應症和複雜的患者群體。

同時，器械設計正日益與生理保護和血管再阻塞緩解緊密結合。藥物釋放型塗層、生物可吸收支架和表面工程技術旨在最大程度地減少新生內膜增生，同時保持血管完整性。這些設計趨勢與改進的影像和導航工具相輔相成，這些工具有助於實現高度針對性的干涉，並減少手術的變異性。器械性能與手術準確性之間的相互作用對訓練、手術指南和臨床實施具有重要意義。

在商業方面，供應商之間的整合以及與科技公司的策略聯盟正在加速一種基於平台的模式，該模式將硬體與數據驅動服務相結合。保險報銷模式正轉向價值認可，鼓勵製造商展現長期療效，而不是只專注於與手術相關的指標。同時，門診手術中心和專科診所的日益普及，迫使製造商開發支援門診工作流程的簡化系統和服務模式。

監管機構正在加強上市後證據要求和真實世界數據收集，推動對綜合登記和長期追蹤的需求。為此，製造商正在投資數據基礎設施、遠端監控和相關人員參與策略。簡而言之，該行業正在從單一產品創新轉向整合材料、程序系統、數據和服務模式的整合解決方案，以展示臨床和經濟價值。

評估近期關稅政策變化如何重塑整個醫療體系的支架供應鏈、製造足跡和商業採購動態

美國將於2025年推出新的關稅政策，促使人們重新評估支架生態系統中的全球製造、採購和定價策略。由於進口關稅影響零件和成品的經濟效益，先前以成本和規模為目標的供應鏈正面臨新的審查。這些關稅壓力正在加速供應商基礎的多元化，並重新激發人們對區域製造的興趣，以降低跨境貿易波動帶來的風險。

雖然擁有垂直整合能力和靈活生產佈局的製造商能夠更輕鬆地適應變化，但依賴專業海外零件供應商的製造商正面臨投入成本波動加劇的問題。為此，許多公司正在協商長期契約，將某些製造業務遷至更靠近終端市場的地方，並探索委託生產安排，以分攤固定成本並保持供應的連續性。這些商業動態正在改變資本配置決策，並影響研發投資的方向。

醫院和醫療系統內的採購團隊也正在調整籌資策略，以降低不斷上升的轉嫁成本。一些供應商正在重新調整其設備選擇通訊協定，並進行更嚴格的合約談判，而其他供應商則正在尋求集團採購安排，以保持對優先技術的使用。付款人和衛生技術評估人員正密切關注手術總成本及其對長期結果的影響，這加劇了對定價透明度和經過驗證的價值提案的需求。

重要的是，關稅環境正在獎勵國內和近岸製造業投資，支持圍繞醫療設備主權和供應鏈韌性的政策對話。同時，成本上升的環境可能會鼓勵以材料效率、模組化製造和可重複使用模具為重點的漸進式創新。整體而言，關稅變化的累積影響並非一次性衝擊，而是推動整個支架產業採購、製造策略和商業性參與結構性轉變的催化劑。

深入了解產品系列、材料選擇、交付系統、臨床用例和醫療保健環境如何影響技術採用和商業策略

細分市場動態揭示了產品類型、材料、交付方式、臨床應用和最終用戶環境的差異化需求促進因素和獨特的策略重點。產品種類繁多，涵蓋專注於心肌重組的冠狀動脈支架、旨在緩解管腔阻塞的胃腸道器械、用於頸動脈和顱內應用的神經血管支架、用於治療頸動脈、股動脈、髂動脈和腎動脈疾病的外周支架，以及用於前列腺和輸尿管疾病的泌尿系統系統支架。每個產品類別都有獨特的操作要求、監管考慮和臨床醫生培訓需求，這些都會影響產品的採用時間表和臨床路徑。

由鈷鉻合金、鎳鈦合金、鉑鉻合金和不銹鋼等合金製成的金屬支架，可為要求嚴格的血管區域提供可靠的徑向強度和抗疲勞性能。聚合物替代品，包括可生物分解和不可生物分解的聚合物組合物，可作為臨時支架，減輕長期植入負擔，並方便未來的干涉。材料創新也與塗層策略和藥物釋放型技術相結合，以塑造癒合反應和長期血管通暢性。

傳統上，球囊擴張型系統用於需要精確部署和高徑向力的情況，而自擴張平台則在曲折血管和動態血管段中提供了靈活性。這些差異會影響器械尺寸演算法、所需影像處理以及操作人員的學習曲線。臨床應用領域多種多樣，包括需要冠狀動脈介入治療的心血管疾病、需要管腔修復的胃腸道阻塞、需要精細顱內導航的神經血管疾病、支架支持腫瘤相關阻塞管理的腫瘤相關應用、以保肢和緩解症狀為重點的周邊動脈疾病，以及強調排尿和緩解阻塞的泌尿器官系統疾病。

終端用戶環境進一步改變了產品需求和商業性模式。門診手術中心和專科診所需要能夠縮短手術時間、簡化物流並實現可預測恢復的設備。同時，醫院和心臟中心優先考慮全面的產品系列、與複雜影像處理設備的整合以及對高度急性病例的強大支援。了解各個細分軸如何相互作用，對於根據特定相關人員的需求客製化臨床證據產生、培訓計劃和商業模式至關重要。

影響美洲、中東和非洲以及亞太地區監管預期、臨床採用模式和製造策略的區域動態

地理動態影響著美洲、歐洲、中東和非洲地區以及亞太地區的創新軌跡、監管要求和醫療服務提供者的採購慣例。在美洲，臨床醫生對微創介入心臟病學的熟悉程度以及主要器械製造商的高度集中，支持了產品的快速臨床應用和迭代改進。法律規範強調可靠的臨床數據和上市後監測，推動產品開發以長期療效證據和性能一致性為導向。

歐洲、中東和非洲地區的監管協調工作並存，但地區差異會影響上市時間和當地臨床實踐模式。在這一廣闊的地區，一些市場擁有強大的臨床研究網路和先進的介入治療能力，而其他市場則專注於擴大可及性和建立手術能力。該地區的醫療保健提供者通常會在成本與展示臨床效用的願望之間取得平衡，從而製定籌資策略和本地分銷商模式。

亞太地區擁有多元化的醫療保健體系、在關鍵市場快速擴張的介入能力以及蓬勃發展的製造生態系統，以滿足區域和全球需求。該地區的創新中心正在推動器材工程和成本敏感型大批量生產的進步。更廣泛地說，每個地區都為臨床夥伴關係、在地化製造投資以及反映報銷結構、供應商能力和患者人口特徵的獨特市場開發方法提供了獨特的機會。

現有企業、專業創新者和策略夥伴關係如何攜手重新定義支架的競爭定位和長期差異化

支架領域的競爭態勢反映出擁有廣泛產品組合的成熟製造商與追求細分技術的新興專業公司之間的平衡。主要企業持續投資於其核心平台的迭代改進，同時透過收購、共同開發契約和商業合作向鄰近領域擴張。這些努力旨在擴大臨床適應症，加速監管核准，並整合先進的影像和輸送系統等互補技術。

中小型創新企業通常專注於研發專用材料、新型藥物釋放型化學技術或獨特的遞送機制，以滿足尚未滿足的臨床需求或簡化流程。成熟企業與創新企業之間的策略聯盟日益普遍，這使得有前景的技術能夠快速擴展，並共用。同時，契約製造製造商和零件供應商在加快產品上市速度和實現靈活生產方面發揮關鍵作用，尤其是在企業應對供應鏈壓力的情況下。

商業性差異化將取決於能否展現長期患者獲益，並提供以服務為導向的解決方案，例如培訓計畫、註冊支援和績效分析。成功將臨床卓越性與營運支援和透明的價值溝通結合的公司，往往能夠在大型醫療服務體系中獲得優先地位。持續的併購、選擇性的夥伴關係模式以及對上市後證據產生的投資，將在短期內塑造競爭地位。

為製造商和相關人員提供實用的策略處方箋，以增強供應彈性、臨床差異化並獲得支架的商業性價值

產業領導者應優先考慮多層面策略，將創新與供應鏈韌性和相關人員價值結合。首先，投資多元化採購和靈活的製造平台可以減少貿易中斷的風險，並在採用加速的情況下幫助企業快速擴張。將部分業務外包，並與委託製造製造商建立策略夥伴關係關係，有助於保持成本競爭力，同時提高前置作業時間的可靠性。

其次，加快研究能顯著改善長期臨床療效的材料和塗層，對於確保有利的採購地位至關重要。減少再血管再阻塞、降低併發症發生率以及簡化再干涉途徑的證明，將引起付款方和大型醫療保健系統的共鳴。將強大的真實世界數據收集和登記納入產品發布，將支持這些主張，並促進基於價值的合約談判。

第三，透過設計滿足門診手術中心、專科診所和重症監護醫院特定需求的設備和服務模式，使商業性模式與最終用戶環境保持一致。雖然門診環境可能更傾向於簡化的系統，以減少手術時間和物流負擔，但三級醫療中心則需要全面的產品組合支援以及與影像生態系統的整合。

第四，積極應對不斷變化的法規和報銷問題，儘早與監管機構溝通，使臨床項目與長期績效目標保持一致，並製定透明的定價模型，以體現總體擁有成本 (TCO) 的效益。最後，在整個生態系統中建立夥伴關係關係，包括影像處理公司、數位醫療服務提供者和學術中心，建構將硬體與數據和服務相結合的平台解決方案，創造可防禦的差異化優勢和更強大的商業性價值提案。

一種透明且可複製的調查方法，結合臨床醫生訪談、監管和科學文獻審查以及強大的三角測量來檢驗見解

調查方法將結構化的一手資料研究與系統的二次研究和嚴格的三角檢驗相結合，以確保信度和效度。一手資料研究包括對介入臨床醫生、採購負責人、監管專家和設備工程師的深入訪談，旨在揭示現實世界中的挑戰、應用促進因素以及未滿足的臨床需求。這些訪談提供了有關不同醫療環境中的程序工作流程、設備偏好和操作限制的背景資訊。

二次研究包括同行評審文獻、監管指南文件、臨床試驗註冊和企業資料披露資訊，旨在揭示技術趨勢、材料科學發展和競爭對手活動。公開的監管文件和指南有助於評估預期證據和核准途徑。整合這些資訊來源使我們能夠識別趨同訊號，並對供應鏈和商業性影響進行情境分析。

資料合成包括將訪談洞察與文獻證據進行交叉檢驗，然後進行定性編碼，以提取跨產品細分、材料、給藥系統、臨床應用和地理區域的主題模式。調查方法強調透明度和可重複性，並清楚記錄關鍵假設和限制。開展了相關人員檢驗會議，以完善觀察，確保其對商業和臨床決策者俱有實際適用性。

全面了解臨床證據、製造敏捷性和生態系統協作將如何決定不斷發展的支架產業的競爭贏家

支架技術和商業化正進入實用創新階段，臨床有效性、營運可行性和供應鏈韌性將決定主導。材料和輸送系統的進步正在拓展血管、神經血管、胃腸道和泌尿系統領域的治療可能性，而監管和報銷環境正將重點轉向長期療效和可證明的價值。醫療保健提供者和付款人越來越期望獲得耐用性和成本效益的證據，這推動了對整合資料策略和結果主導產品定位的關注。

近期貿易政策變化和醫療服務提供者照護模式的轉變，其累積效應凸顯了自適應製造策略和精準商業性方法的重要性。將技術創新與韌性業務營運和清晰的價值創造相結合的公司，最有可能獲得發展動力。從影像合作夥伴到學術網路再到支付方，整個生態系統的協作將加速技術應用，並支援向基於平台的解決方案轉型，將設備與數據和服務相結合。

整體而言，未來將青睞那些將嚴謹的臨床證據、敏捷的生產製造和以客戶為中心的商業模式相結合，從而顯著改善患者治療效果並提升醫療服務提供者效率的組織。果斷執行整合這些要素的策略的公司將創造持久的競爭優勢。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合人工智慧引導成像，實現支架精準放置，減少手術併發症
  • 開發可生物分解的無聚合物藥物釋放型支架，最大限度地減少長期發炎反應
  • 鎂合金生物吸收性的進步提供了更好的血管支持和逐漸吸收
  • 使用 3D 列印技術根據患者需求客製化支架形狀，以最佳化動脈血流並最大程度降低血管再阻塞風險
  • 採用奈米塗層技術遞送靶向抗增殖藥物並防止新內膜增生
  • 主要市場的監管協調將加速新支架平台的核准和市場進入
  • 整合智慧支架感測器的新興遠端監控系統，用於即時血管再阻塞檢測
  • 微創機器人輸送系統擴大支架在周邊動脈疾病的應用
  • 不斷變化的報銷政策對下一代藥物釋放型和生物可吸收支架採用率的影響
  • 透過經濟高效的支架解決方案和本地製造夥伴關係擴大新興市場滲透率

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章支架市場（依產品類型）

  • 冠狀動脈支架
  • 胃腸道支架
  • 神經血管支架
    • 顱外頸動脈支架
    • 顱內支架
  • 周邊動脈狹窄
    • 頸動脈支架
    • 股動脈支架
    • 髂動脈支架
    • 腎動脈支架
  • 泌尿系統支架
    • 攝護腺支架
    • 輸尿管支架

第9章 支架市場（依材料）

  • 金屬支架
    • 鈷鉻合金
    • 鎳鈦合金
    • 鉑鉻
    • 不銹鋼
  • 聚合物支架
    • 可生物分解聚合物
    • 不可生物分解的聚合物

10. 支架市場（依交付方式）

  • 球囊擴張支架
  • 自動擴張型支架

第11章 支架市場（依應用）

  • 心血管疾病
  • 胃腸道阻塞
  • 神經血管疾病
  • 腫瘤學相關應用
  • 周邊動脈疾病（PAD）
  • 泌尿系統疾病

第12章 支架市場（依最終用戶分類）

  • 門診手術中心（ASC）
  • 心臟病中心
  • 醫院
  • 專科診所

第13章 支架市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 支架市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Cook Medical LLC
    • MicroPort Scientific Corporation
    • Lepu Medical Technology Co., Ltd.
    • Cordis Corporation
Product Code: MRR-434CCDA04EF3

The Stents Market is projected to grow by USD 25.33 billion at a CAGR of 7.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.95 billion
Estimated Year [2025] USD 15.01 billion
Forecast Year [2032] USD 25.33 billion
CAGR (%) 7.73%

A concise strategic overview of how clinical innovation, regulatory demands, and care delivery shifts are reshaping stents and interventional device strategies

The stents landscape occupies a pivotal role at the intersection of interventional medicine, device engineering, and health system economics. Advances in materials science, procedural techniques, and imaging technologies have broadened the therapeutic applications of stents beyond coronary interventions to encompass neurovascular, peripheral, gastrointestinal, and urological contexts. Clinicians increasingly favor minimally invasive options that shorten recovery, lower complication rates, and enable outpatient pathways, which in turn reshapes procurement priorities and care delivery models.

Industry participants operate within a complex regulatory and reimbursement environment that demands rigorous clinical evidence and post-market surveillance. Regulatory pathways now emphasize long-term safety and real-world performance, prompting manufacturers to integrate data generation into product strategies. Concurrently, provider systems are exploring value-based contracting and outcome-linked procurement, which raises the bar for comparative clinical benefit and cost-effectiveness.

This report synthesizes technological, clinical, and commercial signals to outline where innovation is creating differentiated value and where operational pressures are prompting strategic realignment. It intends to provide leaders with a clear baseline of contemporary dynamics, enabling them to prioritize investment, optimize supply chains, and refine go-to-market approaches in response to evolving stakeholder expectations.

How materials breakthroughs, design evolution, and commercial platform strategies are driving a paradigm shift in stents development and clinical adoption

The stents landscape is experiencing transformative shifts driven by converging forces across technology, regulation, and healthcare delivery. Materials innovation is redefining device performance as manufacturers move from traditional stainless steel constructs toward advanced alloys and polymer technologies that offer improved flexibility, radiopacity, and biological compatibility. These material advances enable lower-profile delivery systems and more precise deployment, which supports expansion into anatomically challenging indications and complex patient cohorts.

Concurrently, device design is aligning more closely with physiologic preservation and restenosis mitigation. Drug-eluting coatings, bioresorbable scaffolds, and surface engineering techniques aim to minimize neointimal proliferation while preserving vessel integrity. These design trends are complemented by improvements in imaging and navigation tools, which facilitate highly targeted interventions and reduce procedural variability. The interplay between device performance and procedural precision has important implications for training, procedural guidelines, and clinical adoption.

On the commercial front, consolidation among suppliers and strategic partnerships with technology firms are accelerating platform-based approaches that combine hardware with data-driven services. Reimbursement models are shifting toward value recognition, encouraging manufacturers to demonstrate long-term outcomes rather than focusing solely on peri-procedural metrics. At the same time, the provider landscape is decentralizing with greater adoption of ambulatory surgical centers and specialty clinics for selected procedures, prompting manufacturers to develop simplified systems and service models that support outpatient workflows.

Regulatory authorities are reinforcing post-market evidence requirements and real-world data collection, which increases the need for integrated registries and longitudinal follow-up. In response, manufacturers are investing in data infrastructure, remote monitoring, and stakeholder engagement strategies. In short, the industry is transitioning from single-product innovation toward integrated solutions that combine materials, procedural systems, data, and service models to deliver demonstrable clinical and economic value.

Assessment of how recent tariff policy changes are reshaping stents supply chains, manufacturing footprints, and commercial procurement dynamics across healthcare systems

The introduction of new tariff policies in the United States in 2025 has prompted a reassessment of global manufacturing, sourcing, and pricing strategies within the stents ecosystem. Supply chains that were previously optimized for cost and scale are experiencing renewed scrutiny as import levies affect component and finished-device economics. These tariff pressures have accelerated diversification of supplier bases and reignited interest in regional manufacturing to reduce exposure to cross-border trade volatility.

Manufacturers with vertically integrated capabilities or flexible production footprints have found it easier to adapt, while firms reliant on specialized overseas component suppliers have faced increased input cost volatility. In response, many companies are negotiating longer-term agreements, relocating certain manufacturing steps closer to end markets, and exploring toll-manufacturing arrangements to spread fixed costs and maintain continuity of supply. These operational moves are altering capital allocation decisions and influencing where R&D investments are directed.

Procurement teams within hospitals and health systems have also adjusted sourcing strategies to mitigate pass-through cost increases. Some providers have recalibrated device selection protocols and engaged in tighter contract negotiations, while others have pursued group purchasing arrangements to preserve access to preferred technologies. Payers and health technology assessors have been attentive to any implications for total procedure cost and long-term outcomes, which has amplified the need for transparency in pricing and demonstrated value propositions.

Importantly, the tariff environment has created an incentive for domestic and nearshore manufacturing investment, supporting policy conversations around medical device sovereignty and supply chain resilience. At the same time, the heightened cost environment may spur incremental innovation focused on materials efficiency, modular manufacturing, and reusable tooling. Overall, the cumulative impact of tariff changes is less a one-time shock and more a catalyst for structural shifts in sourcing, manufacturing strategy, and commercial engagement across the stents sector.

Insights into how product families, material choices, delivery systems, clinical use cases, and care settings collectively shape technology adoption and commercial strategy

Segment-level dynamics reveal differentiated demand drivers and distinct strategic priorities across product categories, materials, delivery modes, clinical applications, and end-user settings. Product diversity ranges from coronary stents focused on myocardial revascularization to gastrointestinal devices aimed at relieving luminal obstruction, neurovascular stents designed for carotid and intracranial applications, peripheral stents that address carotid, femoral, iliac, and renal arterial disease, as well as urological stents tailored to prostatic and ureteral indications. Each product family carries unique procedural requirements, regulatory considerations, and clinician training needs, which influences adoption timelines and clinical pathways.

Material choice exerts a foundational influence on device behavior, with metallic stents constructed from alloys such as cobalt chromium, nitinol, platinum chromium, and stainless steel delivering established radial strength and fatigue resistance for demanding vascular territories. Polymeric alternatives, including biodegradable and non-biodegradable polymer compositions, present opportunities for temporary scaffolding that could reduce long-term implant burden and facilitate future interventions. Material innovations also intersect with coating strategies and drug-elution technologies, shaping healing responses and long-term vessel patency profiles.

Mode of delivery is a central determinant of clinical use cases and procedure setting, with balloon-expandable systems traditionally used where precise deployment and high radial force are required, while self-expanding platforms offer conformability in tortuous or dynamic vascular segments. These differences impact device sizing algorithms, imaging requirements, and operator learning curves. Clinical application areas span cardiovascular disease leading to coronary interventions, gastrointestinal obstructions that require luminal patency restoration, neurovascular conditions demanding delicate intracranial navigation, oncology-related uses where stents support tumor-related obstruction management, peripheral artery disease where limb salvage and symptom alleviation are priorities, and urological disorders focusing on urinary drainage and obstruction relief.

End-user environments further modulate product requirements and commercial approaches. Ambulatory surgical centers and specialty clinics increasingly demand devices that enable shorter procedure times, simplified logistics, and predictable recovery, whereas hospitals and cardiology centers prioritize comprehensive product portfolios, integration with complex imaging suites, and robust support for high-acuity cases. Understanding how each segmentation axis interacts is essential for tailoring clinical evidence generation, training programs, and commercial models that align with specific stakeholder needs.

Regional dynamics affecting regulatory expectations, clinical adoption patterns, and manufacturing strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Geographic dynamics influence innovation trajectories, regulatory requirements, and provider procurement practices across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinician familiarity with minimally invasive cardiovascular interventions and a concentrated base of leading device manufacturers supports rapid clinical adoption and iterative product improvement. Regulatory frameworks emphasize robust clinical data and post-market surveillance, which steers product development toward long-term outcome evidence and performance consistency.

In Europe, the Middle East, and Africa, regulatory harmonization efforts coexist with regional variations that affect time-to-market and local clinical practice patterns. Several markets within this broad region demonstrate strong clinical research networks and advanced interventional capabilities, while others are focused on expanding access and building procedural capacity. Providers in this region often balance cost considerations with the desire for proven clinical benefit, shaping procurement strategies and local distributor models.

The Asia-Pacific landscape is characterized by diverse healthcare systems, rapidly expanding interventional capability in key markets, and an active manufacturing ecosystem that supplies both regional and global demand. Innovation hubs in this region are contributing to device engineering advances and high-volume, cost-sensitive production. More broadly, each region presents distinct opportunities for clinical partnerships, localized manufacturing investments, and tailored go-to-market approaches that reflect reimbursement structures, provider capabilities, and patient demographics.

How incumbent firms, specialized innovators, and strategic partnerships are converging to redefine competitive positioning and long term differentiation in stents

Competitive dynamics in the stents arena reflect a balance between entrenched manufacturers with broad portfolios and emerging specialists advancing niche technologies. Leading device companies continue to invest in iterative improvements to core platforms while seeking adjacent expansion through acquisitions, co-development agreements, and distribution partnerships. These efforts aim to broaden clinical indications, accelerate regulatory approvals, and integrate complementary technologies such as advanced imaging and delivery systems.

Smaller and mid-sized innovators often focus on specialized materials, novel drug-eluting chemistries, or unique delivery mechanisms that address unmet clinical needs or simplify procedures. Strategic collaborations between incumbents and innovators are increasingly common, enabling rapid scale-up of promising technologies and shared access to clinical trial networks. In parallel, contract manufacturers and component suppliers play a critical role in enabling speed-to-market and flexible production, especially as firms respond to supply chain pressures.

Commercial differentiation increasingly depends on demonstrating longitudinal patient benefits and offering service-oriented solutions such as training programs, registry support, and performance analytics. Companies that successfully combine clinical excellence with operational support and transparent value communication tend to gain preferential positioning with large provider systems. Continued M&A activity, selective partnership models, and investments in post-market evidence generation will shape competitive positioning in the near term.

Practical strategic prescriptions for manufacturers and stakeholders to strengthen supply resilience, clinical differentiation, and commercial value capture in stents

Industry leaders should prioritize a multi-dimensional strategy that aligns innovation with supply chain resilience and stakeholder value. First, investing in diversified sourcing and flexible manufacturing platforms reduces exposure to trade disruptions and supports rapid scaling when adoption accelerates. Nearshoring selected operations and developing strategic partnerships with contract manufacturers can preserve cost competitiveness while improving lead-time reliability.

Second, accelerating materials and coating research that demonstrably improves long-term clinical outcomes will be critical to securing favorable procurement positioning. Demonstrations of reduced restenosis, lower complication rates, and simplified reintervention pathways will resonate with payers and large provider systems. Integrating robust real-world data collection and registries into product launches will support these claims and facilitate value-based contracting discussions.

Third, tailor commercial approaches to end-user environments by designing devices and service models that meet the specific needs of ambulatory surgical centers, specialty clinics, and high-acuity hospitals. Simplified systems that reduce procedure time and logistics burden are likely to find traction in outpatient settings, while comprehensive portfolio support and integration with imaging ecosystems will be essential for tertiary centers.

Fourth, proactively address regulatory and reimbursement evolution by engaging early with authorities, aligning clinical programs to long-term performance endpoints, and preparing transparent pricing models that articulate total cost of care benefits. Finally, cultivate partnerships across the ecosystem - including imaging firms, digital health providers, and academic centers - to build platform solutions that combine hardware with data and services, thereby creating defensible differentiation and stronger commercial value propositions.

A transparent and reproducible methodology combining clinician interviews, regulatory and scientific literature review, and robust triangulation to validate insights

The research approach combined structured primary inquiry, systematic secondary review, and rigorous triangulation to ensure reliability and relevance. Primary research consisted of in-depth interviews with interventional clinicians, procurement leaders, regulatory experts, and device engineers to surface real-world challenges, adoption drivers, and unmet clinical needs. These conversations provided context on procedural workflows, device preferences, and the operational constraints of different care settings.

Secondary research included peer-reviewed literature, regulatory guidance documents, clinical trial registries, and company disclosures to map technological trends, material science developments, and competitive activities. Publicly available regulatory filings and guidance informed the assessment of evidence expectations and approval pathways. The integration of these sources enabled identification of convergent signals and informed scenario analysis around supply chain and commercial impacts.

Data synthesis involved cross-validation between interview insights and documentary evidence, followed by qualitative coding to extract thematic patterns across product segments, materials, delivery systems, clinical applications, and geographic regions. The methodology emphasized transparency and reproducibility, with key assumptions and limitations explicitly documented. Stakeholder validation sessions were conducted to refine findings and ensure practical applicability for commercial and clinical decision-makers.

Synthesis of how clinical evidence, manufacturing agility, and ecosystem collaboration will determine competitive winners in the evolving stents landscape

Stents technology and commercialization are entering a phase of pragmatic innovation where clinical efficacy, operational feasibility, and supply chain resilience will determine leadership. Advances in materials and delivery systems are expanding therapeutic possibilities across vascular, neurovascular, gastrointestinal, and urological domains, while regulatory and reimbursement environments are shifting focus toward long-term outcomes and demonstrable value. Providers and payers increasingly expect evidence of durability and cost-efficiency, which places a premium on integrated data strategies and outcome-driven product positioning.

The cumulative effect of recent trade policy shifts and changing provider care models underscores the importance of adaptive manufacturing strategies and targeted commercial approaches. Firms that align technical innovation with resilient operations and clear value articulation will be best positioned to capture momentum. Collaboration across the ecosystem - from imaging partners to academic networks and payers - will accelerate adoption and support the shift toward platform-based solutions that combine devices with data and services.

Overall, the period ahead favors organizations that combine rigorous clinical evidence, agile manufacturing, and customer-centric commercial models to deliver measurable improvements in patient outcomes and provider efficiency. Those who act decisively to integrate these elements into cohesive strategies will create enduring competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence-guided imaging for precise stent placement to reduce procedural complications
  • 5.2. Development of biodegradable polymer-free drug-eluting stents to minimize long-term inflammatory response
  • 5.3. Advances in magnesium alloy bioresorbable stents offering improved vessel support and gradual absorption
  • 5.4. Use of 3D printing for patient-specific stent geometries to optimize arterial flow and minimize restenosis risk
  • 5.5. Adoption of nanocoating technologies to deliver targeted anti-proliferative drugs and prevent neointimal hyperplasia
  • 5.6. Regulatory harmonization across major markets accelerating approval and market entry of novel stent platforms
  • 5.7. Emergence of remote monitoring systems integrated with smart stent sensors for real-time restenosis detection
  • 5.8. Growth of stent applications in peripheral artery disease driven by minimally invasive robotic-assisted delivery systems
  • 5.9. Impact of evolving reimbursement policies on adoption rates of next-generation drug-eluting and bioabsorbable stents
  • 5.10. Expansion of emerging markets penetration through cost-effective stent solutions and localized manufacturing partnerships

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Stents Market, by Product Type

  • 8.1. Coronary Stents
  • 8.2. Gastrointestinal Stents
  • 8.3. Neurovascular Stents
    • 8.3.1. Extracranial Carotid Artery Stents
    • 8.3.2. Intracranial Stents
  • 8.4. Peripheral Stents
    • 8.4.1. Carotid Artery Stents
    • 8.4.2. Femoral Artery Stents
    • 8.4.3. Iliac Artery Stents
    • 8.4.4. Renal Artery Stents
  • 8.5. Urological Stents
    • 8.5.1. Prostatic Stents
    • 8.5.2. Ureteral Stents

9. Stents Market, by Material

  • 9.1. Metallic Stents
    • 9.1.1. Cobalt Chromium
    • 9.1.2. Nitinol
    • 9.1.3. Platinum Chromium
    • 9.1.4. Stainless Steel
  • 9.2. Polymeric Stents
    • 9.2.1. Biodegradable Polymers
    • 9.2.2. Non-biodegradable Polymers

10. Stents Market, by Mode of Delivery

  • 10.1. Balloon-Expandable Stents
  • 10.2. Self-Expanding Stents

11. Stents Market, by Application

  • 11.1. Cardiovascular Diseases
  • 11.2. Gastrointestinal Obstructions
  • 11.3. Neurovascular Conditions
  • 11.4. Oncology-Related Applications
  • 11.5. Peripheral Artery Disease (PAD)
  • 11.6. Urological Disorders

12. Stents Market, by End User

  • 12.1. Ambulatory Surgical Centers (ASCs)
  • 12.2. Cardiology Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Medtronic plc
    • 16.3.3. Boston Scientific Corporation
    • 16.3.4. Terumo Corporation
    • 16.3.5. B. Braun Melsungen AG
    • 16.3.6. Biotronik SE & Co. KG
    • 16.3.7. Cook Medical LLC
    • 16.3.8. MicroPort Scientific Corporation
    • 16.3.9. Lepu Medical Technology Co., Ltd.
    • 16.3.10. Cordis Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. MIDDLE EAST STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. MIDDLE EAST STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. MIDDLE EAST STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 340. MIDDLE EAST STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 341. MIDDLE EAST STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 342. MIDDLE EAST STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 343. MIDDLE EAST STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 344. MIDDLE EAST STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 345. MIDDLE EAST STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 346. MIDDLE EAST STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 347. MIDDLE EAST STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 348. MIDDLE EAST STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 349. MIDDLE EAST STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 350. MIDDLE EAST STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 351. MIDDLE EAST STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 352. MIDDLE EAST STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 353. MIDDLE EAST STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 354. MIDDLE EAST STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 355. MIDDLE